SARS-CoV-2 spike conformation determines plasma neutralizing activity
Bowen, J. E.; Walls, A. C.; Joshi, A.; Sprouse, K. R.; Stewart, C.; Tortorici, M. A.; Franko, N. M.; Logue, J. K.; Mazzitelli, I. G.; Tiles, S. W.; Ahmed, K.; Shariq, A.; Snell, G.; Iqbal, N. T.; Geffner, J.; Bandera, A.; Gori, A.; Grifantini, R.; Chu, H. Y.; Van Voorhis, W. C.; Corti, D.; Veesler, D.
Show abstract
Numerous safe and effective COVID-19 vaccines have been developed that utilize various delivery technologies and engineering strategies. The influence of the SARS-CoV-2 spike (S) glycoprotein conformation on antibody responses induced by vaccination or infection in humans remains unknown. To address this question, we compared plasma antibodies elicited by six globally-distributed vaccines or infection and observed markedly higher binding titers for vaccines encoding a prefusion-stabilized S relative to other groups. Prefusion S binding titers positively correlated with plasma neutralizing activity, indicating that physical stabilization of the prefusion conformation enhances protection against SARS-CoV-2. We show that almost all plasma neutralizing activity is directed to prefusion S, in particular the S1 subunit, and that variant cross-neutralization is mediated solely by RBD-specific antibodies. Our data provide a quantitative framework for guiding future S engineering efforts to develop vaccines with higher resilience to the emergence of variants and longer durability than current technologies.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Broadly neutralizing antibodies to SARS-related viruses can be readily induced in rhesus macaques 97%
- Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153 97%
- The SARS-CoV-2 mRNA-1273 vaccine elicits more RBD-focused neutralization, but with broader antibody binding within the RBD 97%
Similar papers in this journal
Similar papers in this journal
- Omicron mutations enhance infectivity and reduce antibody neutralization of SARS-CoV-2 virus-like particles 97%
- Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages 96%
- A SARS-CoV-2 vaccine candidate would likely match all currently circulating strains 96%
Similar papers in this journal
- CD4-binding site immunogens elicit heterologous anti-HIV-1 neutralizing antibodies in transgenic and wildtype animals 97%
- Omicron BA.2 breakthrough infection enhances cross-neutralization of BA.2.12.1 and BA.4/BA.5 96%
- Mucosal immunity against SARS-CoV-2 variants of concern including Omicron following vaccination 96%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.